ArticleFrontiers in oncology2024

Case report: Combination therapy of envafolimab with endostar for advanced non-small cell lung cancer with low PD-L1 expression.

Shuo Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.